Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.16% | -35.74% | -16.92% | 56.20% | -18.48% |
| Total Depreciation and Amortization | -4.74% | -8.01% | 3.57% | 128.30% | 19.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.91% | 34.20% | 47.73% | -53.17% | 1.53% |
| Change in Net Operating Assets | 2,109.84% | 164.16% | 58.38% | -123.44% | 155.29% |
| Cash from Operations | 329.88% | -0.05% | 38.25% | -9,765.63% | 101.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 115.00% | -- |
| Total Debt Issued | -787.66% | 37.63% | 133.93% | -- | -- |
| Total Debt Repaid | -576.92% | -- | -- | -- | 81.80% |
| Issuance of Common Stock | -- | -- | -- | -- | -94.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,194.94% | 13.77% | -45.16% | 2,821.09% | -107.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 199.35% | -1,607.41% | -- | -- |
| Net Change in Cash | -199.31% | 256.40% | -225.27% | 372.59% | 41.30% |